Cancer Archives

News and Trends 7 Dec 2022

Step Pharma and Concr to partner on cancer treatment

Step Pharma, which works on CTPS1 inhibition for the targeted treatment of cancer, and Concr, a techbio company with a statistical learning-powered biomarker prediction engine, have entered a partnership to identify biomarkers to improve therapeutic response to inhibitors of cytidine triphosphate synthase 1 (CTPS1), an enzyme to which all cancers appear to be addicted. Concr’s […]

December 7, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 7 Dec 2022

BiVictriX identifies development lead for ADC cancer program

BiVictriX Therapeutics plc, an emerging biotechnology company applying a novel approach to develop next generation cancer therapies using insights derived from frontline clinical experience, has identified a development lead for its BVX001 program. The lead was developed using BiVictriX’s proprietary Bi-Cygni approach, which aims to generate the next-generation of antibody drug conjugates (ADCs) with superior […]

December 7, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Dec 2022

INSPIRE launched to develop inhaled gene therapy for the treatment of lung cancer

OmniSpirant Limited and EVerZom have launched INSPIRE, a €12.8 million ($13.4 million) lung cancer project funded by Horizon Europe. In one of the largest ever grants for preclinical research in lung cancer, OmniSpirant and its European partners in biotechnology, medical devices, cancer research, academia and patient advocacy, met in Galway, Ireland, for the official kick-off […]

December 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Dec 2022

New brain tumor subtypes discovery may help develop treatments for incurable brain cancer

Research led by RCSI University of Medicine and Health Sciences in Ireland has discovered three new subtypes of brain tumor. This could help to identify new and effective therapies. The novel tumor subtypes are forms of glioblastoma, the most common and most aggressive form of adult primary brain cancer with no cure currently available. The […]

December 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Dec 2022

ImaginAb launching clinical trial for renal cancer and malignant melanoma

ImaginAb Inc., which is focused on developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPET) imaging agent and radiopharmaceutical therapy (RPT) products, is starting a phase II clinical trial. The trial, PRETZCEL, which will take place at Hull University Teaching Hospitals NHS Trust in the U.K., will investigate ImaginAb’s investigational CD8 ImmunoPET agent in patients with melanoma or […]

December 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Dec 2022

Startup Graegis developing therapies for radiation side-effects

Graegis Pharmaceuticals, a startup developing new therapies aimed at preventing the side effects of radiotherapies, is set to complete the regulatory nonclinical package allowing entry in clinical trials. The company, founded in the last quarter of 2021, spent the first year of operations running critical experiments on the new therapies, which will target radiation side […]

December 6, 2022 - 2 minutesmins - By Liza Laws

News and Trends 5 Dec 2022

New company Liminatus Pharma Inc to develop three cancer treatments

Clinical-stage biopharma company Liminatus Pharma LLC and Iris Acquisition Corp, a publicly traded special purpose acquisition company formed for the purpose of acquiring or merging with one or more businesses, announced they have entered into a definitive business combination agreement. Upon closing of the transaction, the combined company will be renamed Liminatus Pharma, Inc.. The […]

December 5, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Dec 2022

Singapore researchers develop affordable cancer testing method

Scientists from the National University of Singapore (NUS) have discovered a novel low-cost method of testing for cancers. Called the Heatrich-BS assay, the new test sequences clinical samples that have been heated in order to isolate cancer-specific signatures found in a patient’s blood. The new method provides a promising non-invasive alternative to tissue biopsies. It […]

December 5, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 5 Dec 2022

Faron Pharmaceuticals provides cancer treatment update

Faron Pharmaceuticals Oy has given an update on its phase I/II BEXMAB study, investigating bexmarilimab. Bexmarilimab is Faron’s wholly owned precision immunotherapy asset, in combination with standard of care (SoC) in multiple hematological malignancies. The Finnish company said an azacytidine-refractory acute myeloid leukemia (AML) patient with partial responses as communicated on October 31, 2022, achieved […]

December 5, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 2 Dec 2022

Partnership to deliver oncology workflow for 7 European hospitals

A BC Platforms (BCP) partnership that includes Finland’s Euformatics and Hungary’s Oncompass Medicine has been awarded a contract for the second phase of developing standardized oncology workflows for a buyer consortium of seven European hospitals, represented by the Medical University Graz. The consortium is formed by hospitals from the Medical University of Graz in Austria, […]

December 2, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 2 Dec 2022

Full-Life Technologies acquiring Focus-X Therapeutics

Full-Life Technologies, a global radiotherapeutics company, is acquiring New Jersey-based Focus-X Therapeutics, a company developing targeted radiopharmaceuticals to treat cancer based on peptide engineering technology. The acquisition expands Full-Life’s pipeline, including two compounds nearing clinical trials, provides a second innovative peptide focused discovery platform, and leverages its radiotechnology manufacturing and logistics platforms to advance compounds […]

December 2, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 1 Dec 2022

Trial for HPV16 positive oropharyngeal cancer completes enrolment for phase 2

Netherlands-based ISA Pharmaceuticals B.V., has announced that it has completed enrolment in its phase 2 clinical trial. Named OpcemISA. The trial aims to checkpoint inhibitor therapy in patients with metastatic/advanced 1st and 2nd line HPV16 positive oropharyngeal cancer (OPC). The clinical stage biotech company is developing immunotherapies to treat cancers and infectious diseases, and has […]

December 1, 2022 - 2 minutesmins - By Liza Laws

Knowledge hub

Categories

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer

Step Pharma and Concr to partner on cancer treatment

BiVictriX identifies development lead for ADC cancer program

INSPIRE launched to develop inhaled gene therapy for the treatment of lung cancer

New brain tumor subtypes discovery may help develop treatments for incurable brain cancer

ImaginAb launching clinical trial for renal cancer and malignant melanoma

Startup Graegis developing therapies for radiation side-effects

New company Liminatus Pharma Inc to develop three cancer treatments

Singapore researchers develop affordable cancer testing method

Faron Pharmaceuticals provides cancer treatment update

Partnership to deliver oncology workflow for 7 European hospitals

Full-Life Technologies acquiring Focus-X Therapeutics

Trial for HPV16 positive oropharyngeal cancer completes enrolment for phase 2

Subscribe to our newsletter to get the latest biotech news!

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!